Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 2/20 | 0.61 |
| ▸ | RAB9A | P51151 | 6/20 | 0.56 |
| ▸ | POLB | P06746 | 5/20 | 0.55 |
| ▸ | NPC1 | O15118 | 3/20 | 0.49 |
| ▸ | GAA | P10253 | 1/20 | 0.49 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.49 |
| ▸ | CA12 | O43570 | 1/20 | 0.49 |
| ▸ | CA1 | P00915 | 1/20 | 0.49 |
| ▸ | CA2 | P00918 | 1/20 | 0.49 |
| ▸ | CA4 | P22748 | 1/20 | 0.49 |
| ▸ | CA7 | P43166 | 1/20 | 0.49 |
| ▸ | CA9 | Q16790 | 1/20 | 0.49 |
| ▸ | PTPRG | P23470 | 1/20 | 0.48 |
| ▸ | LPAR2 | Q9HBW0 | 1/20 | 0.46 |
| ▸ | LPAR3 | Q9UBY5 | 1/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.45 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.45 |
| ▸ | LMNA | P02545 | 2/20 | 0.44 |
| ▸ | MAPT | P10636 | 2/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29521131 | 1.00 | CYP1A2 (0.61) | CYP1A2RAB9APOLBNPC1GAA | |
| SCHEMBL3389922 | 0.98 | CYP1A2 (0.62) | CYP1A2RAB9APOLBNPC1GAA | |
| SCHEMBL6231914 | 0.87 | CYP1A2 (0.71) | CYP1A2RAB9APOLBNPC1GAA | |
| SCHEMBL6231027 | 0.83 | CYP1A2 (0.67) | CYP1A2RAB9APOLBNPC1GAA | |
| SCHEMBL6232508 | 0.83 | CYP1A2 (0.67) | CYP1A2RAB9APOLBNPC1GAA | |
| SCHEMBL6232251 | 0.81 | CYP1A2 (0.65) | CYP1A2RAB9APOLBNPC1GAA | |
| SCHEMBL6232914 | 0.81 | CYP1A2 (0.65) | CYP1A2RAB9APOLBNPC1GAA | |
| SCHEMBL6234990 | 0.81 | CYP1A2 (0.65) | CYP1A2RAB9APOLBNPC1GAA | |
| SCHEMBL9658167 | 0.81 | CYP1A2 (0.65) | CYP1A2RAB9APOLBNPC1GAA | |
| SCHEMBL6234337 | 0.81 | CYP1A2 (0.65) | CYP1A2RAB9APOLBNPC1GAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 50 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240226270-A1 | Novel Vaccine Compositions for Porcine Epidemic Diarrhea Virus and Porcine Deltacoronavirus | ZOETIS SERVICES LLC (US) | 2024-07-11 | — | — | US | disclosed |
| WO-2024145150-A1 | PSEUDORABIES VIRUS LIVE ATTENUATED VACCINE FOR PIGS, COMPRISING A DELETION OF GENE UL23 | ZOETIS SERVICES LLC (US) | 2024-07-04 | — | — | WO | disclosed |
| WO-2024130179-A1 | T CELL RECEPTORS BINDING HPV-16 EPITOPES | Repertoire Immune Medicines, Inc. (US) | 2024-06-20 | — | — | WO | disclosed |
| US-20240189420-A1 | PSEUDORABIES VIRUS VACCINE | ZOETIS SERVICES LLC | 2024-06-13 | — | — | US | disclosed |
| US-12005113-B2 | Porcine epidemic diarrhea virus strains and immunogenic compositions therefrom | ZOETIS SERVICES LLC (US) | 2024-06-11 | — | — | US | disclosed |
| EP-4323506-A1 | PSEUDORABIES VIRUS VACCINE | Zoetis Services LLC (US) | 2024-02-21 | — | — | EP | disclosed |
| US-11891417-B2 | Chimeric M. hyorhinis polyprotein for vaccines and diagnostics | IOWA STATE UNIVERSITY RESEARCH FOUNDATION, INC. (US) | 2024-02-06 | — | — | US | disclosed |
| WO-2024026452-A1 | T CELL EPITOPES ASSOCIATED WITH TYPE 1 DIABETES | Repertoire Immune Medicines, Inc. (US) | 2024-02-01 | — | — | WO | disclosed |
| EP-3251692-B1 | HENDRA AND NIPAH VIRUS G GLYCOPROTEIN IMMUNOGENIC COMPOSITIONS | ZOETIS SERVICES LLC (US) | 2023-09-27 | — | — | EP | disclosed |
| EP-4221748-A2 | ATTENUATED PORCINE EPIDEMIC DIARRHEA VIRUS | Zoetis Services LLC (US) | 2023-08-09 | — | — | EP | disclosed |
| WO-2016138421-A1 | PORCINE EPIDEMIC DIARRHEA VIRUS STRAINS AND IMMUNOGENIC COMPOSITIONS THEREFROM | IOWA STATE UNIVERSITY RESEARCH FOUNDATION, INC. (US) | 2016-09-01 | — | — | WO | disclosed |
| US-20160199482-A1 | HENDRA AND NIPAH VIRUS G GLYCOPROTEIN IMMUNOGENIC COMPOSITIONS | ZOETIS SERVICES LLC (US) | 2016-07-14 | — | — | US | disclosed |
| WO-2016007576-A2 | NOVEL VACCINE COMPOSITIONS FOR PORCINE EPIDEMIC DIARRHEA VIRUS AND PORCINE DELTACORONAVIRUS | ZOETIS SERVICES LLC (US) | 2016-01-14 | — | — | WO | disclosed |
| WO-2015095012-A1 | HENDRA AND NIPAH VIRUS G GLYCOPROTEIN IMMUNOGENIC COMPOSITIONS | ZOETIS LLC (US) | 2015-06-25 | — | — | WO | disclosed |
| WO-2015034903-A1 | HENDRA AND NIPAH VIRUS G GLYCOPROTEIN IMMUNOGENIC COMPOSITIONS | ZOETIS LLC (US) | 2015-03-12 | — | — | WO | disclosed |
| US-20150050305-A1 | HENDRA AND NIPAH VIRUS G GLYCOPROTEIN IMMUNOGENIC COMPOSITIONS | ZOETIS LLC (US) | 2015-02-19 | — | — | US | disclosed |
| EP-2707025-A1 | HENDRA AND NIPAH VIRUS G GLYCOPROTEIN IMMUNOGENIC COMPOSITIONS | Zoetis LLC (US) | 2014-03-19 | — | — | EP | disclosed |
| WO-2012158643-A1 | HENDRA AND NIPAH VIRUS G GLYCOPROTEIN IMMUNOGENIC COMPOSITIONS | AH USA 42 LLC (US) | 2012-11-22 | — | — | WO | disclosed |
| US-6492494-B1 | Method of making a fibrin sealant comprising alpha-2-antiplasmin | BRISTOL-MYERS SQUIBB COMPANY | 2002-12-10 | — | — | US | disclosed |
| US-20020064517-A1 | FIBRIN SEALANT AS A TRANSFECTION/TRANSFORMATION VEHICLE FOR GENE THERAPY | VIVOLUTION A/S (DK) | 2002-05-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160199482-A1 | HENDRA AND NIPAH VIRUS G GLYCOPROTEIN IMMUNOGENIC COMPOSITIONS | NIPSNAP3A, NIPSNAP1, FCGR1A | CYP1A2 4645/4885RAB9A 1833/4885POLB 2873/4885 |
| US-20150050305-A1 | HENDRA AND NIPAH VIRUS G GLYCOPROTEIN IMMUNOGENIC COMPOSITIONS | NIPSNAP3A, NIPSNAP1, LY96 | CYP1A2 4810/4885RAB9A 1962/4885POLB 2309/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.